Arch Therapeutics Inc.

US ARTHD

NoneUSD
-(-%)

Last update at 2025-05-21T13:04:10.421501Z

Day Range

--
LowHigh

52 Week Range

0.179.00
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -5.27585M -6.24048M -4.69138M -4.54758M
Minority interest - - - -
Net income -5.27585M -6.24048M -4.69138M -4.54758M
Selling general administrative 4.52M 5.01M 3.76M 3.97M
Selling and marketing expenses - - - -
Gross profit -0.03584M -0.01472M - -
Reconciled depreciation 0.00320M 0.00259M 0.00693M 0.00824M
Ebit - - - -
Ebitda -4.70561M -6.08736M -5.36372M -6.36352M
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -5.70881M -6.37712M -5.37065M -6.37176M
Other operating expenses - - - -
Interest expense 0.57M 0.15M - -
Tax provision - - - -
Interest income - - - -
Net interest income -0.56705M -0.15053M - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 0.02M 0.01M 0.00000M 0.00000M
Total operating expenses 5.72M 6.39M 5.37M 6.37M
Cost of revenue 0.05M 0.03M - -
Total other income expense net 1.00M 0.29M 0.68M 1.82M
Discontinued operations - - - -
Net income from continuing ops -5.27585M -6.24048M -4.69138M -4.54758M
Net income applicable to common shares - - - -
Preferred stock and other adjustments - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 2.60M 3.68M 2.15M 2.90M
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab 6.80M 4.70M 3.65M 3.71M
Total stockholder equity -4.19280M -1.02567M -1.50049M -0.80730M
Deferred long term liab - - - -
Other current liab 1.00M 1.00M - -
Common stock - - - -
Capital stock 0.25M 0.24M 0.19M 0.17M
Retained earnings -55.07277M -49.79692M -43.55644M -38.86506M
Other liab - - - -
Good will - - - -
Other assets - - - -
Cash 0.75M 2.27M 0.96M 2.18M
Cash and equivalents - - - -
Total current liabilities 3.32M 1.73M 0.65M 0.71M
Current deferred revenue - - - -
Net debt 2.62M 0.33M - -
Short term debt - - - -
Short long term debt 0.55M 1.00M 0.04M -
Short long term debt total - - - -
Other stockholder equity - - - -
Property plant equipment - - - -
Total current assets 2.60M 3.67M 2.14M 2.89M
Long term investments - - - -
Net tangible assets - - - -
Short term investments - - - -
Net receivables - - - -
Long term debt 2.81M 1.60M 0.69M -
Inventory 1.41M 1.09M 0.97M 0.35M
Accounts payable 1.33M 0.41M 0.34M 0.53M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.00350M 0.00350M 0.00350M 0.00350M
Deferred long term asset charges - - - -
Non current assets total 0.00554M 0.00874M 0.00805M 0.01M
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments 0.00000M -0.00328M -0.00246M 0.00000M
Change to liabilities - - - -
Total cashflows from investing activities - - - -
Net borrowings - - - -
Total cash from financing activities 2.94M 7.27M 3.83M 2.78M
Change to operating activities - - - -
Net income -5.27585M -6.24048M -4.69138M -4.54758M
Change in cash -1.51970M 1.31M -1.22102M -2.48708M
Begin period cash flow 2.27M 0.96M 2.18M 4.67M
End period cash flow 0.75M 2.27M 0.96M 2.18M
Total cash from operating activities -4.45608M -5.95863M -5.04476M -5.26830M
Issuance of capital stock 0.00000M 6.22M 2.17M 2.75M
Depreciation 0.00320M 0.00259M 0.00693M 0.00824M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory -0.56916M -0.30776M -0.68173M -0.34665M
Change to account receivables - - - -
Sale purchase of stock - - - -
Other cashflows from financing activities - - - -
Change to netincome - - - -
Capital expenditures 0.00000M 0.00328M 0.00246M 0.00000M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 0.77M -0.11161M -0.63971M -0.13213M
Stock based compensation 0.50M 0.50M 0.90M 1.18M
Other non cash items 0.30M - - 0.04M
Free cash flow -4.45608M -5.96190M -5.04721M -5.26830M

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
ARTHD
Arch Therapeutics Inc.
- -% - - - - -
TBB
AT&T Inc
-0.0382 0.17% 21.90 4.60 - - -
CCZ
Comcast Holdings Corp
- -% 61.10 52.13 - - -
STMZF
Scottish Mortgage Investment Trust PLC
-0.04 0.30% 13.46 - - 2.56 -
SHZHY
Shenzhou International Group Holdings Limited
-0.262 3.71% 6.81 24.80 14.99 0.63 3.21 0.51 1.99

Reports Covered

Stock Research & News

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.